Phase 1 BCMA Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Study of BCMA/CD70 CAR-T Therapy for Refractory cSLE

CAR-T Cell TherapySystemic Lupus ErythematosusBCMA

The Children's Hospital of Zhejiang University School of Medicine18 enrolled1 locationNCT06934447

Recruiting

Phase 1

CAR T-cell Therapy Targeting CD19 and BCMA in Patients with AIHA Who Have Failed ≥3 Lines of Therapy.

Autoimmune Hemolytic AnemiaCD19/BCMA CAR T-cellsUniversal Allogeneic CAR T-cells

Institute of Hematology & Blood Diseases Hospital, China15 enrolled1 locationNCT06733610